The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Brain Natriuretic Peptide Is a Prognostic Parameter in Chronic Lung Disease
Abstract
RATIONALE: The detection of pulmonary hypertension in patients with chronic lung disease has prognostic implications. The brain natriuretic peptide (BNP) has been suggested as a noninvasive marker for the presence and severity of pulmonary hypertension. OBJECTIVES: We evaluated circulating BNP levels as a parameter for the presence and severity of pulmonary hypertension in patients with chronic lung disease. METHODS: BNP levels were measured in 176 consecutive patients with various pulmonary diseases. Right heart catheterization, lung functional testing, and a 6-min walk test were performed. The mean follow-up time was nearly 1 yr. MEASUREMENTS AND MAIN RESULTS: Significant pulmonary hypertension (mean pulmonary artery pressure > 35 mm Hg) was diagnosed in more than one-fourth of patients and led to decreased exercise tolerance and life expectancy. Elevated BNP concentrations identified significant pulmonary hypertension with a sensitivity of 0.85 and specificity of 0.88 and predicted mortality. Moreover, BNP served as a risk factor of death independent of lung functional impairment or hypoxemia in uni- and multivariate analysis. CONCLUSION: We suggest BNP as a prognostic marker and as screening parameter for significant pulmonary hypertension in chronic lung disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Lung volumes and forced ventilatory flows
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.005s1693 · Cited by 5,318
(1993) · PubMed · Cited by 3,827
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
(1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.ats4-99 · Cited by 1,902
Clinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Omland, T., Wolf, P. A., & Vasan, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031994 · Cited by 1,527
Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., & Yasue, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115146 · Cited by 1,354
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,255
Badesch, D. B., Tapson, V. F., McGoon, M. D., Brundage, B. H., Rubin, L. J., Wigley, F. M., Rich, S., Barst, R. J., Barrett, P. S., Kral, K. M., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-6-200003210-00002 · Cited by 1,075
Tsutamoto, T., Wada, A., Maeda, K., Hisanaga, T., Maeda, Y., Fukai, D., Ohnishi, M., Sugimoto, Y., & Kinoshita, M. (1997) · Circulation · doi:10.1161/01.cir.96.2.509 · Cited by 963
Echocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease
Arcasoy, S. M., Christie, J. D., Ferrari, V. A., Sutton, M. S. J., Zisman, D. A., Blumenthal, N. P., Pochettino, A., & Kotloff, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1130oc · Cited by 906
Nagaya, N., Nishikimi, T., Uematsu, M., Satoh, T., Kyotani, S., Sakamaki, F., Kakishita, M., Fukushima, K., Okano, Y., Nakanishi, N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.8.865 · Cited by 876
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
international consensus statement
Clements, R. V., & Simanowitz, A. (2000) · Cited by 852
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schott, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 714
Prognostic Factors in COPD Patients Receiving Long-term Oxygen Therapy
Oswald-Mammosser, M., Weitzenblum, E., Quoix, E., Moser, G., Chaouat, A., Charpentier, C., & Kessler, R. (1995) · Chest · doi:10.1378/chest.107.5.1193 · Cited by 523
Thabut, G., Dauriat, G., Stern, J. B., Logeart, D., Levy, A., Marrash-Chahla, R., & Mal, H. (2005) · Chest · doi:10.1378/chest.127.5.1531 · Cited by 494
Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease.
Weitzenblum, E., Hirth, C., Ducolone, A., Mirhom, R., Rasaholinjanahary, J., & Ehrhart, M. (1981) · Thorax · doi:10.1136/thx.36.10.752 · Cited by 488
B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction
Richards, A. M., Nicholls, M. G., Espiner, E. A., Lainchbury, J. G., Troughton, R. W., Elliott, J., Frampton, C., Turner, J., Crozier, I. G., & Yandle, T. G. (2003) · Circulation · doi:10.1161/01.cir.0000070953.76250.b9 · Cited by 436
Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis
OLSCHEWSKI, H., ARDESCHIR GHOFRANI, H., WALMRATH, D., SCHERMULY, R., TEMMESFELD-WOLLBRÜCK, B., GRIMMINGER, F., & SEEGER, W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9810008 · Cited by 410
Nootens, M., Kaufmann, E., Rector, T., Toher, C., Judd, D., Francis, G. S., & Rich, S. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00399-1 · Cited by 317
Clinical significance of brain natriuretic peptide in primary pulmonary hypertension
Leuchte, H. H., Holzapfel, M., Baumgartner, R. A., Ding, I., Neurohr, C., Vogeser, M., Kolbe, T., Schwaiblmair, M., & Behr, J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.051 · Cited by 288
Self-citationHypersensitivity pneumonitis: current concepts
Bourke, S. J., Dalphin, J. C., Boyd, G., McSharry, C., Baldwin, C. I., & Calvert, J. E. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.18s320081 · Cited by 252
Brain Natriuretic Peptide and Exercise Capacity in Lung Fibrosis and Pulmonary Hypertension
Leuchte, H. H., Neurohr, C., Baumgartner, R., Holzapfel, M., Giehrl, W., Vogeser, M., & Behr, J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1142oc · Cited by 219
Self-citationWeitzenblum, E. (2003) · Heart · doi:10.1136/heart.89.2.225 · Cited by 218
Predicting Mortality in Patients With Sarcoidosis Awaiting Lung Transplantation
Shorr, A. F., Davies, D. B., & Nathan, S. D. (2003) · Chest · doi:10.1016/s0012-3692(15)37649-2 · Cited by 217
Pulmonary Arterial Hypertension
Bossone, E., Bodini, B. D., Mazza, A., & Allegra, L. (2005) · Chest · doi:10.1378/chest.127.5.1836 · Cited by 201
brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure
Krüger, S., Graf, J. Ü., Kunz, D., Stickel, T., Hanrath, P., & Janssens, U. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02032-6 · Cited by 189
Pulmonary Hypertension and Cardiac Function in Adult Cystic Fibrosis
Fraser, K. L., Tullis, D. E., Sasson, Z., Hyland, R. H., Thornley, K. S., & Hanly, P. J. (1999) · Chest · doi:10.1378/chest.115.5.1321 · Cited by 161
Gupta, A. S., Rosenman, K. D., Lyon-Callo, S. K., & Hanna, E. A. (2003) · CHEST Journal · doi:10.1378/chest.124.3.922 · Cited by 69
Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension
Wiedemann, R., Ghofrani, H. A., Weißmann, N., SCHERMULY, R. T., Quanz, K., Grimminger, F., Seeger, W., & Olschewski, H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01490-5 · Cited by 58
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citationInterstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
Pulmonary hypertension in chronic lung disease and hypoxia
Nathan, S. D., Barbera, J. A., Gaine, S. P., Harari, S., Martinez, F. J., Olschewski, H., Olsson, K. M., Peacock, A. J., Pepke-Zaba, J., Provencher, S., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01914-2018 · Cited by 757
Pulmonary Hypertension in Chronic Lung Diseases
Seeger, W., Adir, Y., Barberà, J. A., Champion, H., Coghlan, J. G., Cottin, V., De Marco, T., Galiè, N., Ghio, S., Gibbs, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.036 · Cited by 673
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Metadata
- Authors
- Leuchte, H. H., Baumgartner, R. A., Nounou, M. E., Vogeser, M., Neurohr, C., Trautnitz, M., & Behr, J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-01
- Volume
- 173
- Issue
- 7
- Pages
- 744-750
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2124147939
- Cited by
- 284
- References
- 34
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.